Item/Code | CAS No. | Molecular Structure | Therapeutic Area | Certification/Status |
ATS-8 | 125971-94-0 | Dyslipidemia | USA - US-FDA GMP approved - L1: USDMF No. 18835 - API: USDMF No. 26022 EU - CEP 2012-139-Rev01 Japan - MF: 227MF10255 Canada - L1: CA-DMF(2006-162) China - GMP: ZJ20190027 | |
M1 | 42558-54-3 | |||
L1 | 125971-95-1 | |||
L4(API) | 344423-98-9 |
*Product registration and availability vary by country. For more information on product availability, please contact us here.